CD30-targeted CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD30-targeted CAR T cells, covering 2014-10-24 to 2014-10-24. Get the full timeline:
Most recent: Clinical Trial Update: CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) [Phase 1, Phase 2]